US Stock MarketDetailed Quotes

NVRO Nevro

Watchlist

11.250
+0.100+0.90%

Trading May 7 12:38 ET

412.67MMarket Cap-4394P/E (TTM)

Nevro Stock Forum

Moomoo AI

Feb 25 21:35

Nevro's low P/S ratio may be due to its poor revenue outlook. Shareholders accept this as they anticipate no future revenue surprises. These conditions could continue to limit the share price.

Benign Growth For Nevro Corp. (NYSE:NVRO) Underpins Its Share Price

Moomoo AI

Jan 9 01:41

Nevro's growth strategy, prioritizing expansion over steady profits, is viewed as risky, leading to a rapidly declining share price. Despite insider purchases, the company's overall performance has been disappointing, resulting in an annual loss of 8% for shareholders over five years.

Shareholders in Nevro (NYSE:NVRO) Have Lost 89%, as Stock Drops 10% This Past Week

Moomoo AI

Nov 16, 2023 20:30

Insiders buying shares over the past year, including one at a price higher than current, signals positive views of the company's future. While no insider transactions happened in recent three months, activities over the year suggest firm belief in potential.

Nevro Insider Ups Holding By 59% During Year

Moomoo AI

Oct 10, 2023 20:38

The disappointing performance of Nevro's stock may be due to low growth and profit rates. Despite insider purchases, market sentiment towards Nevro remains negative, possibly an overreaction.

Further Weakness as Nevro (NYSE:NVRO) Drops 9.3% This Week, Taking Three-year Losses to 88%

Moomoo AI

Oct 10, 2023 20:30

Despite Nevro's stock price plummeting, insiders buying shares in the past year, the company's ascent looks doubtful without significant profits and revenue growth.

Further Weakness as Nevro (NYSE:NVRO) Drops 9.3% This Week, Taking Three-year Losses to 88%

Movers and Shakers

Oct 10, 2022 20:55

ColumnsToday's Pre-Market Stock Movers: RIVN, EDU, TLRY, F and More

Gapping up
News:
• $PyroGenesis Canada(PYR.US)$ +5.9% (announces that the negotiation for the land-based system to destroy PFAS contract has been suspended and discontinued)
• $Immatics(IMTX.US)$ +3.1% (announces a clinical data update for the IMA203)
• $iPath Series B S&P 500 VIX Short-Term Futures ETN(VXX.US)$ +1.6% (rising with softness in futures)
• $Nevro(NVRO.US)$ +1.4% (comments on $UnitedHealth(UNH.US)$ medical coverage policy u...

Movers and Shakers

Oct 5, 2022 20:42

ColumnsToday's Pre-Market Stock Movers: TSLA, F, KORE, AMLX and More

Gapping up
In reaction to earnings/guidance:
$RPM International(RPM.US)$ +2.4%
Other news:
$Radiant Logistics(RLGT.US)$ +6.8% (to restate FY21 earnings)
$Stellus Capital Investment(SCM.US)$ +3.3% (declares Q4 dividends of $0.34 per share)
$Golden Ocean(GOGL.US)$ +2.5% (authorizes new $100 mln share repurchase program)
$iPath Series B S&P 500 VIX Short-Term Futures ETN(VXX.US)$ +1.5% (rising with pull back in stock futures)
$Pebblebrook Hotel Trust(PEB.US)$ +1.3% (se...

Analysts Notebook

May 5, 2022 19:49

ColumnsTop upgrades and downgrades on 5/5

Upgrades
• $AGNC Investment Corp(AGNC.US)$ : Piper Sandler Upgrades to Overweight from Neutral - PT $13 (from $13.50)
• $Esperion Therapeutics(ESPR.US)$ : JP Morgan Upgrades to Neutral From Underweight
• $Fortinet(FTNT.US)$ : Mizuho Securities Upgrades to Buy from Neutral - PT $350 (from $340)
• $Horizon Technology Finance(HRZN.US)$ : Compass Point Upgrades to Neutral From Sell
• $Momentive Global(MNTV.US)$ : Craig-Hallum Upgrades to Buy from Hold - PT $...

Analysts Notebook

Apr 6, 2022 19:01

ColumnsTop upgrades and downgrades on 4/6

Upgrades
• $Banc of California(BANC.US)$: Raymond James Upgrades to Outperform from Market Perform - PT $22
• $Cullen/Frost Bankers(CFR.US)$: Raymond James Upgrades to Outperform from Market Perform
• $W.W. Grainger(GWW.US)$: Wolfe Research Upgrades to Outperform from Peerperform
• $Invitation Homes Inc(INVH.US)$: Evercore ISI Upgrades to Outperform from In Line - PT $46 (from $44)
• $PCB Bancorp(PCB.US)$: Raymond James Upgrades to Outperform from Market Perfor...

efficentupup

Feb 21, 2022 15:07

Bill Gates says Covid risks have 'dramatically reduced' but another pandemic is coming

Bill Gates said that the risks of severe disease from Covid-19 have "dramatically reduced" but another pandemic is all but certain.
Speaking at Germany's annual Munich Security Conference, Gates said that a potential new pandemic would likely stem from a different pathogen.
Advances in medical technology could cut vaccine production times to six months, Gates added. $Pfizer(PFE.US)$ $Moderna(MRNA.US)$ $Abbott Laboratories(ABT.US)$ $Nevro(NVRO.US)$

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall